Fundz

Aardvark Therapeutics Appoints David Zhang as Class II Director

PUBLIC · AARDOct 08, 2026
New to company · from Abivax S.A.“He previously served as Chief Strategy Officer at Abivax S.A.”

Position

Director

Company

Aardvark Therapeutics

David Zhongwei Zhang, Ph.D., MBA
San DiegoManufacturingBiotechnology

Description

On October 6, 2026, Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as a Class II director of the company, effective October 7, 2026. Dr. Zhang brings over 25 years of experience in clinical program design and regulatory submissions

Quick answer

Aardvark Therapeutics Appoints David Zhang as Class II Director (October 8, 2026). Aardvark Therapeutics is based in San Diego, California, United States.

What did Aardvark Therapeutics announce on October 8, 2026?
On October 6, 2026, Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as a Class II director of the company, effective October 7, 2026.
Where did David Zhongwei Zhang, Ph.D., MBA work before joining Aardvark Therapeutics?
David Zhongwei Zhang, Ph.D., MBA joins from Abivax S.A.
What does Aardvark Therapeutics do?
Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation,...
Where is Aardvark Therapeutics based?
Aardvark Therapeutics is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Everest Medicines (October 9, 2026), TETRAPHARM (October 9, 2026), Jazz Pharmaceuticals plc (October 9, 2026) and Modern Chemistry Labs (MCL) (October 7, 2026) also announced leadership changes within 45 days of Aardvark Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Manufacturing and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Aardvark Therapeutics, and when

A new leader at Aardvark Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Aardvark Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aardvark Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aardvark Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aardvark Therapeutics

Location

4370 La Jolla Village Drive

San Diego, California, United States

About

Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation, and other indications. Aardvark's lead compound, oral ARD-101, is a potent bitter taste receptor (TAS2R) pan-agonist that stimulates enteroendocrine cells of the digestive tract to release multiple gut-peptide hormones including GLP-1 and the satiety hormone Cholecystokinin (CCK), which activates gut-brain neurologic signaling to mediate hunger. ARD-101 has demonstrated an ability to reduce hunger when used alone or in combination with currently available GLP-1 therapies. Based on promising clinical data from an ongoing ARD-101 trial, the FDA has granted the drug both Orphan Drug designation and Rare Pediatric Rare Disease designation in PWS.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aardvark Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bryan
Senior decision-maker at this company
••••••••@••••••••

See Bryan's verified email →

Tom
Likely contact at this company
••••••••@••••••••

See Tom's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aardvark Therapeutics's next move

Learn about Strategic plan

Aardvark Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.